RT Journal Article
SR Electronic
T1 Reimbursement for HPV Vaccine Cost in the Private Sector: A Comparison Across Specialties
JF The Annals of Family Medicine
JO Ann Fam Med
FD American Academy of Family Physicians
SP 344
OP 346
DO 10.1370/afm.2990
VO 21
IS 4
A1 Zhu, Yenan
A1 Lin, Yueh-Yun
A1 Li, Ruosha
A1 He, Cara
A1 Lairson, David R.
A1 Deshmukh, Ashish A.
A1 Sonawane, Kalyani
YR 2023
UL http://www.annfammed.org/content/21/4/344.abstract
AB The human papillomavirus (HPV) vaccine is the most expensive of all routinely recommended pediatric vaccines. Adequate cost reimbursement by 3rd-party payers is a critical enabling factor for clinicians to continue offering vaccines. This study found that net returns from HPV vaccine cost reimbursements are lowest for family physicians ($0.34/dose) and highest for pediatricians ($5.08/dose). Furthermore, a $1 increment in return was associated with an increase in HPV vaccine doses administered (highest for family physicians; 0.08% per dollar). Reimbursement for HPV vaccine costs by private payers is adequate; however, return margins are small for non-pediatric specialties.